The pages linked below capture the Rx Response program's mission statement, members, history, and frequently asked questions, as well as describe how the normal bio-pharmaceutical supply chain operates and the criteria that prompt a public health response. Click on any of the links below for more information or send an email to contactus@rxresponse.org.
Captures the Rx Response mission statement and how Rx Response partners and members work to ensure the preservation of public health during an emergency.
Lists the official Rx Response member organizations, including the private sector (involved in the manufacturing, distribution, or dispensing of bio-pharmaceutical medicines) and the public sector (involved in setting up public shelters to take in those impacted by the event), who coordinate to preserve public health through the continued delivery of and access to medicines during a public health emergency.
Describes the normal flow of medicines through the bio-pharmaceutical supply chain and identifies where breaks in the chain may occur, due to natural disaster (hurricane, earthquake, etc), man-made threat (terrorist attack, cyber attack, etc) or public health emergency (pandemic, biological attack, etc).
Describes the circumstances under which the Rx Response program activates to address potential bio-pharmaceutical supply chain issues and protect public health.
Lists frequently asked questions and answers about the Rx Response program, including on the program structure, program history and motivation for planning, emergency activation and response, and communication and collaboration tools.
Captures the history of the Rx Response program, including how and why the program was created.
If you cannot find specific information on our website, feel free to send a request for information to the Rx Response operations center, located at PhRMA's headquarters in Washington D.C. In addition, feel free to call or fax the numbers below, or send an email to contactus@rxresponse.org.
Rx Response
c/o PhRMA
950 F Street, NW
Suite 300
Washington, DC 20004
Phone: (202) 835-3400
Fax: (202) 835-3414